Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer

Información

DOI:
https://doi.org/10.1002/14651858.CD012952Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 febrero 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Salud digestiva

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Yazan H Nofal

    Correspondencia a: Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

    [email protected]

  • Yaser Abu Dail

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Yazan Assaf

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Hayan Abo Samra

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Fatima Abbas

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Ammar Hamzeh

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Nahla Alhaj Hasan

    Health services, IRC: International Rescue Committee, Malikieh, Syrian Arab Republic

Contributions of authors

NAH revised the protocol and provided general advice.

YHN (the contact person) organised the review teamwork, wrote the ‘Objectives’, ‘Unit of analysis issues’, ‘Sensitivity analysis’, ‘Search methods for identification of studies’, ‘Acknowledgements’, ‘Contributions of authors’ and 'Declarations of interest' sections of the protocol, responded to peer reviewer comments, checked the data entered into the RevMan 5.3, and commented on every section in the protocol main text.

YAD and YHN wrote the ’Criteria for considering studies for this review’ section for the protocol. YAD also checked the correct use of grammar in the ‘Description of the condition’ ‘Description of the intervention’, ‘Why it is important to do this review’ sections, and commented on every section in the main text of the protocol.

YA wrote the ‘Description of the condition’ and ‘Glossary of terms’ sections of the protocol, checked the correct use of grammar, entered data into RevMan 5.3, and commented on the sections ‘Description of the intervention’, ‘How the intervention might work’, ‘Why it is important to do this review’, ‘Objectives’, ‘Criteria for considering studies for this review’, ‘Measures of treatment effect’, ‘Unit of analysis issues’, and ‘Subgroup analysis and Investigation of heterogeneity’.

HAS wrote the ‘Data extraction and management’, ‘Measures of treatment effect’, ‘Dealing with missing data’, ‘Assessment of heterogeneity’, and ‘Assessment of reporting biases’ sections of the protocol, and commented on the section ‘Criteria for considering studies for this review’.

FA wrote the ‘Assessment of risk of bias in included studies’ and ‘Reaching conclusions’ sections of the protocol, checked for the correct use of grammar, and commented on the ‘Description of the intervention’, ‘Objectives’, and ‘Criteria for considering studies for this review’ sections.

HAS and FA wrote the section ‘How the intervention might work’.

HAS, FA, and YHN wrote the section ‘Why it is important to do this review’.

FA and YHN wrote the section ‘Subgroup analysis and investigation of heterogeneity’.

HAS wrote the ‘Description of the intervention’ section.

AH wrote the ‘Selection of studies’ and ‘Data synthesis’ sections of the protocol, and commented on the section ‘Criteria for considering studies for this review’.

Sources of support

Internal sources

  • Damascus University, Syrian Arab Republic.

  • Association for Evidence Based Medicine, Syrian Arab Republic.

    Provided training courses. www.a4ebm.org

External sources

  • No sources of support supplied

Declarations of interest

YHN: none known.

YAD: none known.

YA: none known.

HAS: none known.

FA: none known.

AH: none known.

NAH: none known.

Acknowledgements

We acknowledge the help and support of the Cochrane Upper Gastrointestinal Diseases Review Group. We thank Karin Dearness (Managing Editor) and Kieran Elliot (Managing Editor). We thank Yuhong Yuan (Trials Search Co‐ordinator) for developing and executing the search strategies, and Gillian Gummer for copy editing the protocol.

The authors would also like to thank the editors and peer referees who provided comments to improve the protocol naming: Sarah Rhodes (Editor), Marilyn Walsh (Consumer).

The methods section of this protocol is based on a standard template used by the Cochrane Gastrointestinal and Pancreatic Diseases Review Group.

We thank Mohammad Baraa Keifo for co‐writing the section ‘Description of the intervention’ and for commenting on the section ‘Description of the condition'.

We thank Dr Fares Alahdab for answering our questions regarding methodological aspects.

We are most grateful to Dr Adib Essali for his generosity in teaching and mentoring.

Version history

Published

Title

Stage

Authors

Version

2018 Feb 12

Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer

Protocol

Yazan H Nofal, Yaser Abu Dail, Yazan Assaf, Hayan Abo Samra, Fatima Abbas, Ammar Hamzeh, Nahla Alhaj Hasan

https://doi.org/10.1002/14651858.CD012952

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.